Suture Embedding Acupuncture for Chronic Low Back Pain
Primary Purpose
Low Back Pain
Status
Unknown status
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
Suture Embedding Acupuncture
Sham Acupuncture
Sponsored by
About this trial
This is an interventional treatment trial for Low Back Pain
Eligibility Criteria
Inclusion Criteria:
- cLBP lasting for at least the last 3 months.
- 10-cm visual analogue scale (VAS) for bothersomeness of LBP exceeding 4.
- Nonspecific and uncomplicated LBP that was intact on neurological examination.
Exclusion Criteria:
- Exclusion criteria are sciatic pain (i.e., if a patient reported typical radiating pain in the leg as well as one or more neurological indications of nerve root tension or neurological deficit)
- Pain mainly below the knee; serious spinal disorders including malignancy, vertebral fracture, spinal infection, inflammatory spondylitis and cauda equine compression; history of previous spinal surgery or scheduled surgery to address a chronic disease that could interfere with treatment effects (e.g., cardiovascular disease, diabetic neuropathy, fibromyalgia, rheumatoid arthritis, dementia, and epilepsy);
- Acupuncture treatment of LBP during the previous month
- Conditions that could compromise the safety of acupuncture (e.g., clotting disorders, taking anticoagulant agent, pregnancy, and seizure disorders);
- Severe psychiatric or psychological disorder
- Use of corticosteroids, narcotics or herbal medicine to treat LBP within one month.
Sites / Locations
- Taipei medical university hospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
Suture Embedding Acupuncture
Sham acupuncture
Arm Description
Suture Embedding Acupuncture 1 time for two weeks, total 3 times.
Sham Acupuncture 1 time for two weeks, total 3 times.
Outcomes
Primary Outcome Measures
VAS
The patients will be asked to mark, on a 10 cm VAS (0, absence of bothersomeness; 10, the worst bothersomeness imaginable)
Secondary Outcome Measures
Oswestry Disability Index (ODI)
The self-completed questionnaire contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel
EQ-5D
In description part, health status is measured in terms of five dimensions (5D); mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
In evaluation part, the respondents evaluate their overall health status using the visual analogue scale.
Full Information
NCT ID
NCT03685864
First Posted
September 25, 2018
Last Updated
March 9, 2020
Sponsor
Taipei Medical University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03685864
Brief Title
Suture Embedding Acupuncture for Chronic Low Back Pain
Official Title
Suture Embedding Acupuncture for Chronic Low Back Pain: A Randomized, Sham-Controlled Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
March 2020
Overall Recruitment Status
Unknown status
Study Start Date
October 12, 2018 (Actual)
Primary Completion Date
July 31, 2021 (Anticipated)
Study Completion Date
August 31, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Taipei Medical University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Chronic low back pain (cLBP) is a common public health issue, and it is one of the main causes of disability among adults of working age. Suture embedding acupuncture is one of the most often used interventions for the treatments of cLBP. The investigators will investigate the efficacy and safety of suture embedding acupuncture for cLBP in this single center, parallel, randomized, sham-controlled clinical trial.
Detailed Description
Suture embedding acupuncture is one of the most often used interventions for the treatments of chronic low back pain (cLBP). The investigators will investigate the efficacy and safety of suture embedding acupuncture for cLBP in this single center, parallel, randomized, sham-controlled clinical trial.
Participants will be randomized into 2 groups (real acupuncture and sham acupuncture) by central allocation. Randomized participants will complete a questionnaire that solicited information regarding age, sex, marital status, occupation, education, and medical history. The blinding credibility of the treatments will be evaluated at the end of the treatment.
Real Suture embedding Acupuncture for Treatment Group To make the real suture embedding acupuncture treatment reflect an ordinary clinical practice condition, participants received standardized acupuncture treatment. That treatment was accomplished by selecting a group of acupuncture points that predefined. Acupuncture points will be bladder meridian pattern acupuncture points including Shenshu (BL23), Qihaishu (BL24), Dachangshu (BL25), and Yimmen (BL37). Treatment will be given using sterile, disposable stainless steel 23G or 25G injection needles with 1 mm 5.0 Vicryl suture inside the needle. The needles will be inserted perpendicular to a depth of 5 to 35 mm depending on the acupuncture point, which was followed by manual stimulation by bidirectional rotation to induce Deqi sensation. Deqi was defined as a dull, localized, and aching sensation, which signaled the attainment of qi. After the Deqi sensation being achieved, the suture will be embedded with a sterile stainless steel needle. After needle removal, a 5mm × 5 mm sterile tape will be adhered to the needle hole. Patients will be asked not to remove the tape unless necessary.
Sham Acupuncture for Control Group Treatment will be given using sterile, disposable stainless steel 30G or 32G acupuncture needles. The acupuncture points will be the same as real suture embedding acupuncture group. The needles will be inserted perpendicular to a depth of 5 to 35 mm depending on the acupuncture point and will be pulled up immediately. After sham acupuncture, the point will be adhered a sterile tape as real group. Patients will be asked not to remove the tape unless necessary.
Outcome Measures Primary Outcome Measure The primary outcome measure is VAS for LBP. To understand the impact of cLBP on the participants' life, VAS for bothersomeness is chosen instead of pain intensity. The participants will be asked to mark, on a 10 cm VAS (0, absence of bothersomeness; 10, the worst bothersomeness imaginable), the average degree of bothersomeness due to LBP experienced within the most recent 1 week from the day of the assessment. This measurement has substantial validity. Bothersomeness of LBP will be measured at baseline, 2-, 4-, 8-, 12-, 16-, 20-, and 24-week. The primary endpoint is the 8-week follow-up (i.e., 4 wk after finishing all of the treatments).
Secondary Outcome Measures VAS for pain intensity is a simple method evaluating the subjective intensity of pain. Pain intensity will be measured in the same way as VAS for bothersomeness. Validity of its reliability has been demonstrated. The Chinese version Oswestry Disability Index (ODI) is used to measure back pain-related dysfunction. Health-related quality of life will be measured using the well-validated EuroQol 5 dimensions (EQ-5D). A higher score is indicative of a better general health status. Participants satisfaction will be evaluated with 5 point scale (1 is worst, and 5 is best)
Statistical Analyses To determine appropriate sample size, the VAS mean difference between the 2 groups will be assumed to be 1.5 and standard deviation to be 2.73 cm with significance level([alpha]) = 0.05 and power(1-ß) = 0.80. For the equal allocation for the 2 groups, total sample size considering dropout rate of 20% will be calculated as 130 subjects, which means that at least 104 subjects would finally be required after drop outs. The investigators performed the Shapiro-Wilk normality test to determine whether or not the sample values followed a normal distribution and finally assumed normality according to the test result. For all statistical analysis, SPSS 18.0 (SPSS Inc., Chicago, IL) will be used. Significance level will be set at P < 0.05. Per protocol (PP) analysis included all participants randomized and followed up until the last follow-up point.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Back Pain
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
130 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Suture Embedding Acupuncture
Arm Type
Experimental
Arm Description
Suture Embedding Acupuncture 1 time for two weeks, total 3 times.
Arm Title
Sham acupuncture
Arm Type
Sham Comparator
Arm Description
Sham Acupuncture 1 time for two weeks, total 3 times.
Intervention Type
Other
Intervention Name(s)
Suture Embedding Acupuncture
Intervention Description
Suture Embedding Acupuncture at 8 acupoints (both sides of BL23, BL24, BL25, BL37). Receiving intervention 1 time in 2 weeks, and total receive 3 times.
Intervention Type
Other
Intervention Name(s)
Sham Acupuncture
Intervention Description
Sham Acupuncture at 8 acupoints (both sides of BL23, BL24, BL25, BL37). Receiving intervention 1 time in 2 weeks, and total receive 3 times.
Primary Outcome Measure Information:
Title
VAS
Description
The patients will be asked to mark, on a 10 cm VAS (0, absence of bothersomeness; 10, the worst bothersomeness imaginable)
Time Frame
2 week
Secondary Outcome Measure Information:
Title
Oswestry Disability Index (ODI)
Description
The self-completed questionnaire contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel
Time Frame
2 week
Title
EQ-5D
Description
In description part, health status is measured in terms of five dimensions (5D); mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
In evaluation part, the respondents evaluate their overall health status using the visual analogue scale.
Time Frame
2 week
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
cLBP lasting for at least the last 3 months.
10-cm visual analogue scale (VAS) for bothersomeness of LBP exceeding 4.
Nonspecific and uncomplicated LBP that was intact on neurological examination.
Exclusion Criteria:
Exclusion criteria are sciatic pain (i.e., if a patient reported typical radiating pain in the leg as well as one or more neurological indications of nerve root tension or neurological deficit)
Pain mainly below the knee; serious spinal disorders including malignancy, vertebral fracture, spinal infection, inflammatory spondylitis and cauda equine compression; history of previous spinal surgery or scheduled surgery to address a chronic disease that could interfere with treatment effects (e.g., cardiovascular disease, diabetic neuropathy, fibromyalgia, rheumatoid arthritis, dementia, and epilepsy);
Acupuncture treatment of LBP during the previous month
Conditions that could compromise the safety of acupuncture (e.g., clotting disorders, taking anticoagulant agent, pregnancy, and seizure disorders);
Severe psychiatric or psychological disorder
Use of corticosteroids, narcotics or herbal medicine to treat LBP within one month.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Meng-Huang Wu, PhD
Phone
886 2 27372181
Ext
3740
Email
alumni@tmu.edu.tw
First Name & Middle Initial & Last Name or Official Title & Degree
Chien-Huang Lin
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chien-Huang Lin, PhD
Organizational Affiliation
Taipei Medical University
Official's Role
Study Chair
Facility Information:
Facility Name
Taipei medical university hospital
City
Taipei
ZIP/Postal Code
110
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Meng-Huang Wu, PhD
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
11498898
Citation
Fan Z. Observation on 105 cases of duodenal bulbar ulcer treated by combined therapy of catgut embedding and Chinese drugs. J Tradit Chin Med. 2001 Jun;21(2):111-5. No abstract available.
Results Reference
background
PubMed Identifier
23026870
Citation
Cho YJ, Song YK, Cha YY, Shin BC, Shin IH, Park HJ, Lee HS, Kim KW, Cho JH, Chung WS, Lee JH, Song MY. Acupuncture for chronic low back pain: a multicenter, randomized, patient-assessor blind, sham-controlled clinical trial. Spine (Phila Pa 1976). 2013 Apr 1;38(7):549-57. doi: 10.1097/BRS.0b013e318275e601.
Results Reference
background
PubMed Identifier
15838072
Citation
Manheimer E, White A, Berman B, Forys K, Ernst E. Meta-analysis: acupuncture for low back pain. Ann Intern Med. 2005 Apr 19;142(8):651-63. doi: 10.7326/0003-4819-142-8-200504190-00014. Erratum In: Ann Intern Med. 2005 Jun 7;142(11):950-1.
Results Reference
background
Learn more about this trial
Suture Embedding Acupuncture for Chronic Low Back Pain
We'll reach out to this number within 24 hrs